Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
| Image |  |
|---|---|
| Description | scientific article published on 14 February 2019 |
| Author/s |
author: Annunziata Gloghini Lorenza Rimassa Armando Santoro Laura Toppo Filippo Pietrantonio Sara Lonardi |
| Publication date | February 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |